跳至主要内容
临床试验/ISRCTN45993953
ISRCTN45993953已完成未知

Osteogenesis and osteoclast inhibition in rheumatoid arthritis patients after more than 4 years of treatment with bisphosphonates or bisphosphonates with pitavastatin over an 18 month follow up: a randomized controlled trial

Tokyo Metropolitan Bokutoh Hospital (Japan)0 个研究点目标入组 77 人开始时间: 2012年9月4日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
77

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged over 40 years old
  • 2. Pre-menopausal patients with rheumatoid arthritis, and not planning pregnancy
  • 3. Postmenopausal patients
  • 4. Patients receiving bisphosphonates
  • 5. Patients receiving bisphosphonates and not receiving statins who diagnozed hyperlipidemia

排除标准

  • 1. Adverse or allergic reactions to statins
  • 2. Severe liver function disturbance
  • 3. Severe renal function disturbance
  • 4. Patients with rheumatoid arthritis during pregnancy or during nuring
  • 5. Patients with probability of pregnancy
  • 6. Patients receiving statins
  • 7. Patients with other sever complications

研究者

发起方
Tokyo Metropolitan Bokutoh Hospital (Japan)

相似试验